All In Biotech

Drug Trial Radar · NCT04185402

Azithromycin Reduction to Reach Elimination of Trachoma

Last checked: Nov 20, 2026Latest source record: Mar 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 3,931 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

3,931

Actual

Start

May 29, 2021

Primary completion

Dec 18, 2024

Study completion Dec 18, 2024

Sponsor

Lead sponsor
University of California, San FranciscoAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Programme National de Santé Oculaire (PNSO); National Eye Institute (NEI)
First posted
Dec 4, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 1 month
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The investigators propose a randomized controlled trial of discontinuation versus continuation of annual mass azithromycin distribution in hypoendemic communities of Maradi, Niger. The investigators will randomize communities with up to 20% Trachomatous Inflammation - Follicular (TF) prevalence following at least 5 years of mass azithromycin distribution to discontinuation or continuation of 3 additional years of annual mass azithromycin distribution.

Conditions

  • Trachoma

Interventions

  • AzithromycinDrug

    In study communities randomized to the Azithromycin Continuation arm, all individuals aged 1 month and older will receive a single mass distribution of azithromycin several weeks after the baseline and 36-month monitoring visits. In study communities randomized to Azithromycin Discontinuation, participants will receive no treatment.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ocular Chlamydia Measured in a Population-based Sample of 0-9 Year-old ChildrenTime frame: 36 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Programme National de Santé Oculaire (PNSO)

    Niamey, Niger

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.